MRK EBITDA Growth
Merck & Co. · EBITDA Growth
MRK EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-44.38%period ending
MRK TTM EBITDA YoY % (42.95% → -44.38%)
Year-over-year change
High-resolution chart · PNG
MRK ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -44.3828% | |
| -27.3941% | |
| 9.9393% | |
| 43.7653% | |
| 21.643% | |
| 190.2127% | |
| 272.1732% | |
| 56.1734% | |
| 102.7181% | |
| -55.0365% | |
| -67.5956% | |
| -43.0414% | |
| -55.9728% | |
| -0.3542% | |
| 19.0782% | |
| 79.2623% | |
| 141.2448% | |
| 83.7137% | |
| 52.9522% | |
| -27.0159% | |
| -41.1258% | |
| -34.6842% | |
| -26.8928% | |
| 3.5517% | |
| -1.5282% | |
| 7.1177% | |
| 13.6286% | |
| 19.2857% | |
| 50.2232% | |
| 39.2286% | |
| 18.2673% | |
| 53.9337% | |
| -3.5667% | |
| 3.5787% | |
| 10.3678% | |
| -34.9203% | |
| -14.1489% | |
| -14.331% | |
| -13.2953% | |
| -43.0368% | |
| -41.363% | |
| -47.0845% | |
| -49.6155% | |
| 61.3263% | |
| 53.9278% | |
| 70.8933% | |
| 85.2857% | |
| 10.6401% | |
| 6.3491% | |
| -9.1684% | |
| -18.8535% | |
| -22.1669% | |
| -19.6592% | |
| -5.2002% | |
| 6.1156% | |
| 27.962% | |
| 51.9864% | |
| 47.2095% | |
| 58.8173% | |
| -19.0191% | |
| -41.5109% | |
| -40.5479% | |
| -46.7952% | |
| 33.1783% | |
| 126.5886% | |
| 118.059% | |
| 64.8893% | |
| 7.0925% | |
| -23.588% | |
| -19.8687% | |
| 46.1215% | |
| 79.6081% | |
| 91.9396% | |
| 81.7194% | |
| 27.7246% | |
| -5.6637% | |
| -22.8583% | |
| -23.1393% | |
| -21.383% | |
| -8.0152% | |
| 3.853% | |
| -3.542% | |
| -6.1724% | |
| -15.5458% | |
| -24.2526% | |
| -16.7074% | |
| -16.6452% | |
| -19.059% | |
| -8.582% | |
| -12.1098% | |
| -10.2484% | |
| 0.2759% | |
| -6.0193% | |
| -3.7899% | |
| -3.5838% | |
| -5.1853% | |
| 1.4358% | |
| 2.5689% | |
| 4.74% | |
| 13.0051% |